Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

237 Views

A4. Treatment of antimicrobial resistant infections

Poster Session: Treatment of Antimicrobial Resistant Infections

(P-1520) Addition of Relebactam Increases Susceptibility to Imipenem Among Imipenem-Intermediate Pseudomonas aeruginosa: Asia/Pacific SMART 2018-2022

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

CD

C. Andrew DeRyke, PharmD

IHMA
Schaumburg, Illinois, United States
WC

Wei-Ting Chen, MD

Regional Director of Medical Affairs
MSD Taiwan
Taipei, Taipei, Taiwan
FS

Fakhar Siddiqui, MD, MBA

Merck & Co., Inc.
Rahway, New Jersey, United States
Katherine Young, M.S. (she/her/hers)

Senior Principal Scientist
Merck
Rahway, New Jersey, United States
MM

Mary Motyl, Ph.D.

Distinguished Senior Principal Scientist
Merck
Rahway, New Jersey, United States
DS

Daniel F. Sahm, PhD

VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States